- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01336205
Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
October 13, 2014 updated by: AstraZeneca
An Open-Label 52-week Study to Assess the Long-Term Safety of NKTR-118 in Opioid-Induced Constipation (OIC) in Patients With Non-Cancer-Related Pain
The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
844
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Athens, Alabama, United States
- Research Site
-
Birmingham, Alabama, United States
- Research Site
-
Huntsville, Alabama, United States
- Research Site
-
Mobile, Alabama, United States
- Research Site
-
Pell City, Alabama, United States
- Research Site
-
-
Arizona
-
Garden Grove, Arizona, United States
- Research Site
-
Goodyear, Arizona, United States
- Research Site
-
Mesa, Arizona, United States
- Research Site
-
Phoenix, Arizona, United States
- Research Site
-
Tucson, Arizona, United States
- Research Site
-
Tuscon, Arizona, United States
- Research Site
-
-
Arkansas
-
Jonesboro, Arkansas, United States
- Research Site
-
Little Rock, Arkansas, United States
- Research Site
-
North Little Rock, Arkansas, United States
- Research Site
-
Sherwood, Arkansas, United States
- Research Site
-
-
California
-
Arcadia, California, United States
- Research Site
-
Chino, California, United States
- Research Site
-
Encino, California, United States
- Research Site
-
Fremont, California, United States
- Research Site
-
Garden Grove, California, United States
- Research Site
-
Huntington Park, California, United States
- Research Site
-
La Mesa, California, United States
- Research Site
-
Laguna Hills, California, United States
- Research Site
-
Lakewood, California, United States
- Research Site
-
Long Beach, California, United States
- Research Site
-
Oceanside, California, United States
- Research Site
-
Orange, California, United States
- Research Site
-
Pasadena, California, United States
- Research Site
-
Riverside, California, United States
- Research Site
-
San Bernardino, California, United States
- Research Site
-
San Diego, California, United States
- Research Site
-
San Francisco, California, United States
- Research Site
-
Santa Ana, California, United States
- Research Site
-
Walnut Creek, California, United States
- Research Site
-
Whittier, California, United States
- Research Site
-
-
Colorado
-
Colorado Springs, Colorado, United States
- Research Site
-
-
Connecticut
-
Stamford, Connecticut, United States
- Research Site
-
-
Florida
-
Boynton Beach, Florida, United States
- Research Site
-
Bradenton, Florida, United States
- Research Site
-
Brooksville, Florida, United States
- Research Site
-
Chiefland, Florida, United States
- Research Site
-
Clearwater, Florida, United States
- Research Site
-
Crystal River, Florida, United States
- Research Site
-
Daytona Beach, Florida, United States
- Research Site
-
Debary, Florida, United States
- Research Site
-
Deerfield Beach, Florida, United States
- Research Site
-
Delray Beach, Florida, United States
- Research Site
-
Edgewater, Florida, United States
- Research Site
-
Eustis, Florida, United States
- Research Site
-
Fort Myers, Florida, United States
- Research Site
-
Inverness, Florida, United States
- Research Site
-
Jackson, Florida, United States
- Research Site
-
Jacksonville, Florida, United States
- Research Site
-
Jupiter, Florida, United States
- Research Site
-
Largo, Florida, United States
- Research Site
-
Lauderhill, Florida, United States
- Research Site
-
Miami, Florida, United States
- Research Site
-
Naples, Florida, United States
- Research Site
-
North Miami, Florida, United States
- Research Site
-
Ocala, Florida, United States
- Research Site
-
Orange City, Florida, United States
- Research Site
-
Orlando, Florida, United States
- Research Site
-
Oviedo, Florida, United States
- Research Site
-
Pembroke Pines, Florida, United States
- Research Site
-
Pinellas Park, Florida, United States
- Research Site
-
Plantation, Florida, United States
- Research Site
-
Port Orange, Florida, United States
- Research Site
-
Port St. Lucie, Florida, United States
- Research Site
-
South Miami, Florida, United States
- Research Site
-
St. Doral, Florida, United States
- Research Site
-
St. Petersburg, Florida, United States
- Research Site
-
Tamarac, Florida, United States
- Research Site
-
Tampa, Florida, United States
- Research Site
-
West Palm, Florida, United States
- Research Site
-
West Palm Beach, Florida, United States
- Research Site
-
Winter Park, Florida, United States
- Research Site
-
-
Georgia
-
Alpharetta, Georgia, United States
- Research Site
-
Atlanta, Georgia, United States
- Research Site
-
Columbus, Georgia, United States
- Research Site
-
Marietta, Georgia, United States
- Research Site
-
Suwanee, Georgia, United States
- Research Site
-
Tucker, Georgia, United States
- Research Site
-
-
Idaho
-
Boise, Idaho, United States
- Research Site
-
-
Illinois
-
Bloomington, Illinois, United States
- Research Site
-
Chicago, Illinois, United States
- Research Site
-
Peoria, Illinois, United States
- Research Site
-
Schaumburg, Illinois, United States
- Research Site
-
-
Indiana
-
Evansville, Indiana, United States
- Research Site
-
Indianapolis, Indiana, United States
- Research Site
-
-
Iowa
-
Council Bluffs, Iowa, United States
- Research Site
-
-
Kansas
-
Kansas City, Kansas, United States
- Research Site
-
Lansing, Kansas, United States
- Research Site
-
Overland Park, Kansas, United States
- Research Site
-
Wichita, Kansas, United States
- Research Site
-
-
Kentucky
-
Louisville, Kentucky, United States
- Research Site
-
-
Louisiana
-
New Orleans, Louisiana, United States
- Research Site
-
Shreveport, Louisiana, United States
- Research Site
-
-
Maryland
-
Baltimore, Maryland, United States
- Research Site
-
Columbia, Maryland, United States
- Research Site
-
Hollywood, Maryland, United States
- Research Site
-
Pikesville, Maryland, United States
- Research Site
-
Reisterstown, Maryland, United States
- Research Site
-
-
Massachusetts
-
Watertown, Massachusetts, United States
- Research Site
-
-
Michigan
-
Calamazoo, Michigan, United States
- Research Site
-
Traverse City, Michigan, United States
- Research Site
-
-
Missouri
-
St Louis, Missouri, United States
- Research Site
-
St. Louis, Missouri, United States
- Research Site
-
-
Nebraska
-
Bellevue, Nebraska, United States
- Research Site
-
Fremont, Nebraska, United States
- Research Site
-
Lincoln, Nebraska, United States
- Research Site
-
Omaha, Nebraska, United States
- Research Site
-
-
Nevada
-
Henderson, Nevada, United States
- Research Site
-
Las Vegas, Nevada, United States
- Research Site
-
-
New Jersey
-
Clifton, New Jersey, United States
- Research Site
-
Freehold, New Jersey, United States
- Research Site
-
Lumberton, New Jersey, United States
- Research Site
-
Toms River, New Jersey, United States
- Research Site
-
Voorhees, New Jersey, United States
- Research Site
-
Willingboro, New Jersey, United States
- Research Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States
- Research Site
-
-
New York
-
Great Neck, New York, United States
- Research Site
-
Hartsdale, New York, United States
- Research Site
-
New York, New York, United States
- Research Site
-
North Massapequa, New York, United States
- Research Site
-
-
North Carolina
-
Charlotte, North Carolina, United States
- Research Site
-
Elkin, North Carolina, United States
- Research Site
-
Flat Rock, North Carolina, United States
- Research Site
-
Harrisburg, North Carolina, United States
- Research Site
-
Mooresville, North Carolina, United States
- Research Site
-
Morganton, North Carolina, United States
- Research Site
-
Morrisville, North Carolina, United States
- Research Site
-
Winston-salem, North Carolina, United States
- Research Site
-
-
Ohio
-
Akron, Ohio, United States
- Research Site
-
Beavercreek, Ohio, United States
- Research Site
-
Centerville, Ohio, United States
- Research Site
-
Toledo, Ohio, United States
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States
- Research Site
-
-
Pennsylvania
-
Downingtown, Pennsylvania, United States
- Research Site
-
Jenkintown, Pennsylvania, United States
- Research Site
-
Norristown, Pennsylvania, United States
- Research Site
-
Philadelphia, Pennsylvania, United States
- Research Site
-
Pottstown, Pennsylvania, United States
- Research Site
-
-
South Carolina
-
Anderson, South Carolina, United States
- Research Site
-
Charleston, South Carolina, United States
- Research Site
-
Greer, South Carolina, United States
- Research Site
-
Myrtle Beach, South Carolina, United States
- Research Site
-
-
Tennessee
-
Chattanooga, Tennessee, United States
- Research Site
-
Clarksville, Tennessee, United States
- Research Site
-
Jackson, Tennessee, United States
- Research Site
-
Memphis, Tennessee, United States
- Research Site
-
Milan, Tennessee, United States
- Research Site
-
New Tazewell, Tennessee, United States
- Research Site
-
-
Texas
-
Austin, Texas, United States
- Research Site
-
Dallas, Texas, United States
- Research Site
-
Houston, Texas, United States
- Research Site
-
Hurst, Texas, United States
- Research Site
-
Lexington, Texas, United States
- Research Site
-
Marshall, Texas, United States
- Research Site
-
San Antonio, Texas, United States
- Research Site
-
Sugarland, Texas, United States
- Research Site
-
Victoria, Texas, United States
- Research Site
-
-
Utah
-
Clinton, Utah, United States
- Research Site
-
Ogden, Utah, United States
- Research Site
-
Saint George, Utah, United States
- Research Site
-
Salt Lake City, Utah, United States
- Research Site
-
West Jordan, Utah, United States
- Research Site
-
-
Virginia
-
Richmond, Virginia, United States
- Research Site
-
Springfield, Virginia, United States
- Research Site
-
Virginia Beach, Virginia, United States
- Research Site
-
-
Wisconsin
-
Middleton, Wisconsin, United States
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 84 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Provision of written informed consent prior to any study-specific procedures.
- NEW PATIENTS ONLY: Self-reported active symptoms of OIC at screening (<3 SBMs/week and experiencing >1 reported symptom of hard/lumpy stools, straining, or sensation of incomplete evacuation/anorectal obstruction in at least 25% of the BMs over the previous 4 weeks); and Documented confirmed OIC (<3 SBMs/week on average over the 2-week OIC confirmation period.
- PATIENTS ENROLLING FROM OTHER NKTR-118 STUDIES: Receiving a stable maintenance opioid regimen consisting of a total daily dose of 30 mg to 1000 mg or oral morphine, or equianalgesic amount(s) of 1 or more opioid therapies.
- FOR PATIENTS RANDOMIZED TO RECEIVE NKTR-118: Willingness to stop all laxatives and other bowel regimens including prune juice and herbal products throughout the 52-week treatment period, and to use only bisacodyl as rescue medication if BM has not occurred within at least 72 hours of the last recorded BM.
Exclusion Criteria:
- Patients receiving Opioid regimen for treatment of pain related to cancer.
- History of cancer within 5 years from first study visit with the exception of basal cell cancer and squamous cell skin cancer.
- Medical conditions and treatments associated with diarrhea, intermittent loose stools, or constipation.
- Other issues related to the gastrointestinal tract that could impose a risk to the patient.
- Pregnancy or lactation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Oral Treatment
|
25 mg oral tablet once daily
|
Active Comparator: 2
Oral treatment
|
As prescribed by the investigator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Patients Experiencing at Least One Adverse Event (AE)
Time Frame: Baseline (Week 0) to end of the follow-up period
|
The incidence of patients experiencing at least one AE during the randomized treatment and follow-up periods was calculated.
|
Baseline (Week 0) to end of the follow-up period
|
Incidence of Patients Experiencing AEs That Resulted in Discontinuation of Investigational Product (IP)
Time Frame: Baseline (Week 0) to end of the follow-up period
|
The incidence of patients experiencing AEs that resulted in discontinuation of IP during the randomized treatment or follow-up periods was calculated.
|
Baseline (Week 0) to end of the follow-up period
|
Incidence of Patients Experiencing Severe Adverse Events (SAEs)
Time Frame: Baseline (Week 0) to end of the follow-up period
|
The incidence of patients experiencing SAEs during the randomized treatment and follow-up periods was calculated.
|
Baseline (Week 0) to end of the follow-up period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
April 14, 2011
First Submitted That Met QC Criteria
April 14, 2011
First Posted (Estimate)
April 15, 2011
Study Record Updates
Last Update Posted (Estimate)
October 20, 2014
Last Update Submitted That Met QC Criteria
October 13, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D3820C00008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid-Induced Constipation (OIC)
-
AstraZenecaCompletedOpioid-Induced Constipation (OIC)United States, Germany, Australia, Slovakia
-
AstraZenecaNektar TherapeuticsCompletedOpioid Induced Constipation (OIC)United States
-
ShionogiRecruitingOpioid-Induced Constipation (OIC)France
-
AstraZenecaCompletedOpioid-Induced Constipation (OIC)United States, Australia, Slovakia, Germany
-
Theravance BiopharmaCompletedOpioid-induced Constipation (OIC)United States
-
AstraZenecaCompletedOpioid-Induced Constipation (OIC)Croatia, Sweden, United States, Czech Republic, Spain, Hungary, United Kingdom, Belgium
-
Methodist Health SystemWithdrawn
-
Alkermes, Inc.Completed
-
Amsterdam UMC, location VUmcRadboud University Medical Center; University Medical Center Groningen; UMC Utrecht and other collaboratorsRecruitingConstipation, Opioid-InducedNetherlands
-
Kyowa Kirin Pharmaceutical Development LtdTerminatedOpioid Induced ConstipationNetherlands, United Kingdom
Clinical Trials on NKTR-118
-
AstraZenecaCompletedOpioid-Induced Constipation (OIC)Croatia, Sweden, United States, Czech Republic, Spain, Hungary, United Kingdom, Belgium
-
AstraZenecaCompletedOpioid-Induced Constipation (OIC)United States, Australia, Slovakia, Germany
-
AstraZenecaTerminatedOpioid-Induced ConstipationCroatia, United States, Bulgaria, United Kingdom, Poland, Romania, Belgium, Puerto Rico, Slovakia, Australia, South Africa, Czech Republic, Germany, Spain
-
Dow Pharmaceutical SciencesUnknownPlaque PsoriasisUnited States
-
AstraZenecaCompletedOpioid-Induced Constipation (OIC)United States, Germany, Australia, Slovakia
-
AstraZenecaNektar TherapeuticsCompletedOpioid Induced Constipation (OIC)United States
-
AstraZenecaCompletedHepatic; Functional DisturbanceUnited States
-
Bausch Health Americas, Inc.Dow Pharmaceutical SciencesCompleted
-
AstraZenecaCompletedHealthy VolunteersUnited Kingdom